Pharmaceutical Industry Issues Call for Collective Action to Address the Rising Global Burden of Chronic Disease

Contributed by: Business Wire

Logo

Images

The global pharmaceutical trade body calls on countries to enable innovation, mobilize investment, drive implementation, and ensure accountability ahead of the 4th UN High-Level Meeting on NCDs and Mental Health this September. (Graphic: Business Wire)

Business Wire embedded0

Tags

Biotechnology

Diabetes

Health

Neurology

Other Health

Public Policy/Government

Oncology

Mental Health

Research

Infectious Diseases

General Health

Science

Public Policy

Cardiology

IFPMA

More Like This

PR Newswire associated0

Access Accelerated and the World Bank Collaborate via New Technical Partnership in Cooperation with Results for Development to Build a Coalition Aimed at Closing the Health Financing Gap for Noncommunicable Diseases in Low and Middle-Income Countries

Air pollution over Shanghai illustrating the climate health crisis. (Photo: Business Wire)

Global Healthcare Leaders Advance Sector Decarbonisation Ahead of COP28

Global donors pledge over US$777 million to defeat neglected tropical diseases and improve the lives of 1.6 billion people at the Reaching the Last Mile Forum at COP28

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

PR Newswire associated0

New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health Agenda

International Diabetes Federation and Sanofi Global Health Unit collaborate to strengthen diabetes response in 40 countries

World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are